Market Cap 3.48B
Revenue (ttm) 1.19B
Net Income (ttm) 2.00M
EPS (ttm) N/A
PE Ratio 13.99
Forward PE 14.48
Profit Margin 0.17%
Debt to Equity Ratio -1.27
Volume 10,663,200
Avg Vol 2,123,940
Day's Range N/A - N/A
Shares Out 137.88M
Stochastic %K 79%
Beta 0.70
Analysts Strong Sell
Price Target $29.40

Company Profile

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorp...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 804 379 1090
Address:
10710 Midlothian Turnpike, Suite 125, North Chesterfield, United States
EchoBolt
EchoBolt Oct. 30 at 10:01 PM
0 · Reply
SlatsMcSlappy
SlatsMcSlappy Oct. 30 at 9:37 PM
$INDV .72A vs .38E 3Q25, .54 3Q24 Revenues were 21% over est Raised revenue and earnings guidance
0 · Reply
howardlindzon
howardlindzon Oct. 30 at 5:37 PM
$INDV the ozempic of opiodes still working
0 · Reply
howardlindzon
howardlindzon Oct. 30 at 5:36 PM
$INDV shoulda coulda
1 · Reply
7o4
7o4 Oct. 30 at 3:08 PM
$INDV ha ☺️ ⌚
0 · Reply
thetrackisfast
thetrackisfast Oct. 30 at 11:55 AM
$INDV yup! Those inside days!
0 · Reply
thetrackisfast
thetrackisfast Oct. 20 at 4:42 PM
$INDV definitely NOT an inside day
0 · Reply
thetrackisfast
thetrackisfast Oct. 20 at 3:28 PM
$INDV possible inside day big drop in volume
1 · Reply
AcrossMarkets
AcrossMarkets Oct. 17 at 9:17 PM
Addex Therapeutics (NASDAQ: $ADXN) is catching eyes! With low float, a strategic collaboration with Indivior ($INDV), and potential $330M milestone payments, traders are buzzing. Do you think ADXN is about to skyrocket or will it retrace? 🔥 Full story 👉 https://www.acrossmarkets.icu/2025/10/addex-therapeutics-adxn-soars-on.html
2 · Reply
thetrackisfast
thetrackisfast Oct. 15 at 6:14 AM
$INDV was inside 10/13
0 · Reply
Latest News on INDV
Indivior PLC (INDV) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 3:56 PM EDT - 6 hours ago

Indivior PLC (INDV) Q3 2025 Earnings Call Transcript


UK's Indivior to re-domicile to US after listing move

Oct 1, 2025, 9:35 AM EDT - 4 weeks ago

UK's Indivior to re-domicile to US after listing move


Indivior to Participate in Upcoming Investor Events

Aug 20, 2025, 12:00 PM EDT - 2 months ago

Indivior to Participate in Upcoming Investor Events


Indivior's Strategic Turnaround Gains Traction Post-Q2 2025

Aug 5, 2025, 5:39 PM EDT - 3 months ago

Indivior's Strategic Turnaround Gains Traction Post-Q2 2025


Indivior PLC (INDV) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 5:22 AM EDT - 3 months ago

Indivior PLC (INDV) Q2 2025 Earnings Call Transcript


Indivior Appoints Tony Kingsley to the Board of Directors

Jun 24, 2025, 4:12 PM EDT - 4 months ago

Indivior Appoints Tony Kingsley to the Board of Directors


Indivior Announces Patrick Barry as Chief Commercial Officer

May 27, 2025, 8:30 AM EDT - 5 months ago

Indivior Announces Patrick Barry as Chief Commercial Officer


Indivior: Trying To Break Addiction

Apr 28, 2025, 12:12 PM EDT - 6 months ago

Indivior: Trying To Break Addiction


Indivior PLC (INDV) Q1 2025 Earnings Conference Call Transcript

Apr 24, 2025, 10:45 AM EDT - 6 months ago

Indivior PLC (INDV) Q1 2025 Earnings Conference Call Transcript


Indivior Announces Q1 2025 Financial Results

Apr 24, 2025, 2:00 AM EDT - 6 months ago

Indivior Announces Q1 2025 Financial Results


Indivior Announces Further Changes to Board of Directors

Mar 4, 2025, 8:40 AM EST - 8 months ago

Indivior Announces Further Changes to Board of Directors


UK's Indivior appoints Joe Ciaffoni as CEO

Feb 27, 2025, 2:48 AM EST - 8 months ago

UK's Indivior appoints Joe Ciaffoni as CEO


Indivior PLC (INDV) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 2:26 PM EST - 9 months ago

Indivior PLC (INDV) Q4 2024 Earnings Call Transcript


UK's Indivior forecasts 17% decline in 2025 revenue

Feb 20, 2025, 2:55 AM EST - 9 months ago

UK's Indivior forecasts 17% decline in 2025 revenue


Indivior Announces FY and Q4 2024 Financial Results

Feb 20, 2025, 2:00 AM EST - 9 months ago

Indivior Announces FY and Q4 2024 Financial Results


Indivior PLC (INDV) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 2:02 PM EDT - 1 year ago

Indivior PLC (INDV) Q3 2024 Earnings Call Transcript


Indivior Announces Q3 2024 Financial Results

Oct 24, 2024, 2:00 AM EDT - 1 year ago

Indivior Announces Q3 2024 Financial Results


EchoBolt
EchoBolt Oct. 30 at 10:01 PM
0 · Reply
SlatsMcSlappy
SlatsMcSlappy Oct. 30 at 9:37 PM
$INDV .72A vs .38E 3Q25, .54 3Q24 Revenues were 21% over est Raised revenue and earnings guidance
0 · Reply
howardlindzon
howardlindzon Oct. 30 at 5:37 PM
$INDV the ozempic of opiodes still working
0 · Reply
howardlindzon
howardlindzon Oct. 30 at 5:36 PM
$INDV shoulda coulda
1 · Reply
7o4
7o4 Oct. 30 at 3:08 PM
$INDV ha ☺️ ⌚
0 · Reply
thetrackisfast
thetrackisfast Oct. 30 at 11:55 AM
$INDV yup! Those inside days!
0 · Reply
thetrackisfast
thetrackisfast Oct. 20 at 4:42 PM
$INDV definitely NOT an inside day
0 · Reply
thetrackisfast
thetrackisfast Oct. 20 at 3:28 PM
$INDV possible inside day big drop in volume
1 · Reply
AcrossMarkets
AcrossMarkets Oct. 17 at 9:17 PM
Addex Therapeutics (NASDAQ: $ADXN) is catching eyes! With low float, a strategic collaboration with Indivior ($INDV), and potential $330M milestone payments, traders are buzzing. Do you think ADXN is about to skyrocket or will it retrace? 🔥 Full story 👉 https://www.acrossmarkets.icu/2025/10/addex-therapeutics-adxn-soars-on.html
2 · Reply
thetrackisfast
thetrackisfast Oct. 15 at 6:14 AM
$INDV was inside 10/13
0 · Reply
JFDI
JFDI Oct. 14 at 3:17 PM
0 · Reply
JFDI
JFDI Oct. 13 at 8:06 PM
$INDV High & Tight Alerts at 24.50 & 22
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 29 at 11:10 AM
$INDV Really good write-up that perfectly summarizes INDV's present situation. So if you want to bring your INDV knowledge up to date or just discover INDV, this is required reading. https://beyondspx.com/quote/INDV/analysis/indivior-s-strategic-reinvigoration-unlocking-sublocade-s-potential-amidst-market-shifts-nasdaq-indv
0 · Reply
SweepCastApp
SweepCastApp Sep. 29 at 10:33 AM
$INDV: Unusual Options Activity Alerted CALL flow observed 723x contracts at Strike price of $25 Exp on 10/17/2025 with Premium of $40K and showing BULLISH Sentiment
0 · Reply
StockConsultant
StockConsultant Sep. 26 at 2:34 PM
$INDV Indivior stock, nice setup and rally off the 22.22 support area, watch for an upcoming top of range breakout at https://stockconsultant.com/?INDV
0 · Reply
BellaDante5
BellaDante5 Sep. 26 at 12:14 AM
$INDV I had all my shares set to sell at $25 and it spiked to $25 on Webull. I’m not sure exactly how it happened because I don’t see any other spikes on other apps but I’ll buy back in in the $22 range. Easy money
0 · Reply
howardlindzon
howardlindzon Sep. 23 at 12:19 PM
$INDV wow. what’s the story here
0 · Reply
BellaDante5
BellaDante5 Sep. 23 at 7:12 AM
$INDV holy after hours
0 · Reply
BellaDante5
BellaDante5 Sep. 19 at 9:30 PM
$INDV let’s push back to $24.50 next week
0 · Reply
JarvisFlow
JarvisFlow Aug. 27 at 5:55 PM
Craig-Hallum updates rating for Indivior ( $INDV ) to Buy, target set at 27 → 34.
0 · Reply
kharlus
kharlus Aug. 19 at 9:58 PM
$INDV time for a pullback …
0 · Reply
Doozio
Doozio Aug. 15 at 3:23 PM
$INDV YO so 💪 it appears only chop n shakeouts to come. Hard to see a real correction wen a $PGNY is still chop chop huckleberries getting medicated thru XBI 🐒🍌🧠⏰♾️
0 · Reply